Menu
Svensk version

BONESUPPORT - Change in the management team

Lund, Sweden, 17.30 CET, 24 April 2019 – BONESUPPORT, an emerging leader in orthobiologics for the management of bone voids, today announces that Vikram Johri will leave his role as GM & EVP Commercial Operations Eurow and BONESUPPORT as of today. On an interim basis all positions having reported into the GM & EVP Commercial Operations Eurow will report directly into the CEO. Further announcements on the structuring of the region will follow.

 

About BONESUPPORT

BONESUPPORT (Nasdaq Stockholm: BONEX) develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver and a Premarket approval filing with the FDA (USA) for its gentamicin eluting product is planned in 2020. The company is based in Lund, Sweden, and the net sales amounted to SEK 97 million in 2018. Please visit www.bonesupport.com for more information. 

BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.

For more information contact:

BONESUPPORT

Emil Billbäck, CEO
+46 (0) 46 286 53 70

 

Håkan Johansson, CFO
+46(0) 46 286 53 70
ir@bonesupport.com

 

Cord Communications
Charlotte Stjerngren
+46 (0)708 76 87 87
charlotte.stjerngren@cordcom.se
www.cordcom.se

Downloads

Press release PDF (87.63 KB)

BONESUPPORT, Tue Sep 10, 2019

@BONESUPPORT_AB are proud to be Platinum sponsor again for @EBJIS 2019, starts Thursday 12th September in Antwerp. https://t.co/z6XXYBsipT

BONESUPPORT, Fri Aug 2, 2019

@MSIS 2019 CERAMENT Bone Void Filler injectable bone graft substitute remodels to bone 6-12 months. Meet… https://t.co/vbLgu854rt

BONESUPPORT, Fri Aug 2, 2019

@BONESUPPORT_AB is exhibiting at the MSIS congress NYC. Hear more about CERAMENT G resorbable injectable antibiotic… https://t.co/JJ8wURMyNT